Filters: Keyword is Substance Withdrawal Syndrome [Clear All Filters]
"Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms." Journal of substance abuse treatment 29, no. 4 (2005): 307-12. Abstract
"Commentary on Larney (2010): a call to action-opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners." Addiction (Abingdon, England) 105, no. 2 (2010): 224-5.
"Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market." The American journal of drug and alcohol abuse 35, no. 2 (2009): 68-72. Abstract
"Opioid dependence: rationale for and efficacy of existing and new treatments." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S173-7. Abstract
"The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 37, no. 4 (2003): 476-82. Abstract
"Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients." Drug and alcohol dependence 118, no. 2-3 (2011): 326-34. Abstract
"Risk for delirium tremens in patients with alcohol withdrawal syndrome." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 23, no. 2 (2002): 83-94. Abstract
"Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial." Addictive behaviors 35, no. 5 (2010): 537-40. Abstract
